These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1646419)

  • 1. Prenatal exposure to benzodiazepine--I. Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function.
    Chesley S; Lumpkin M; Schatzki A; Galpern WR; Greenblatt DJ; Shader RI; Miller LG
    Neuropharmacology; 1991 Jan; 30(1):53-8. PubMed ID: 1646419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic and receptor binding changes during chronic lorazepam administration.
    Fahey JM; Pritchard GA; Grassi JM; Pratt JS; Shader RI; Greenblatt DJ
    Pharmacol Biochem Behav; 2001; 69(1-2):1-8. PubMed ID: 11420062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent alterations in GABAA receptor binding and function after prenatal lorazepam administration in the chick.
    Miller LG; Roy RB; Weill CL; Lopez F
    Brain Res Bull; 1989 Sep; 23(3):171-4. PubMed ID: 2555030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.
    Miller LG; Greenblatt DJ; Roy RB; Summer WR; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):177-82. PubMed ID: 2455789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal lorazepam exposure: 4. Persistent alterations in pentylenetetrazole-induced seizure threshold and GABA-dependent chloride uptake after prenatal lorazepam exposure.
    Koff JM; Miller LG
    Pharmacol Biochem Behav; 1995 Aug; 51(4):721-4. PubMed ID: 7675850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal lorazepam administration is associated with GABAA receptor alterations in late embryonic and mature chicks.
    Miller LG; Weill CL; Roy RB
    Neurotoxicology; 1989; 10(3):517-22. PubMed ID: 2560535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorazepam administration during embryonic development alters GABAA receptor binding and function.
    Miller LG; Weill CL; Roy RB; Gaver A
    Brain Res Dev Brain Res; 1988 Dec; 44(2):241-6. PubMed ID: 2852070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [35S]TBPS binding but not benzodiazepine binding.
    Miller LG; Chesley S; Galpern WR; Greenblatt DJ; Shader RI
    Pharmacol Biochem Behav; 1991 Oct; 40(2):429-32. PubMed ID: 1666676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration.
    Miller LG; Woolverton S; Greenblatt DJ; Lopez F; Roy RB; Shader RI
    Biochem Pharmacol; 1989 Nov; 38(21):3773-7. PubMed ID: 2557030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.
    Miller LG; Greenblatt DJ; Barnhill JG; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):170-6. PubMed ID: 2839660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
    Galpern WR; Miller LG; Greenblatt DJ; Shader RI
    Br J Pharmacol; 1990 Dec; 101(4):839-42. PubMed ID: 1964820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration.
    Galpern WR; Lumpkin M; Greenblatt DJ; Shader RI; Miller LG
    Psychopharmacology (Berl); 1991; 104(2):225-30. PubMed ID: 1652144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
    Allan AM; Baier LD; Zhang X
    J Pharmacol Exp Ther; 1992 May; 261(2):395-402. PubMed ID: 1374467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations.
    Miller LG; Galpern WR; Greenblatt DJ; Lumpkin M; Shader RI
    J Pharmacol Exp Ther; 1990 Jul; 254(1):33-8. PubMed ID: 2164100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration.
    Kang I; Miller LG
    Br J Pharmacol; 1991 Jun; 103(2):1285-7. PubMed ID: 1653067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lorazepam tolerance and withdrawal on GABAA receptor operated chloride channels in mice selected for differences in ethanol withdrawal severity.
    Allan AM; Baier LD; Zhang X
    Life Sci; 1992; 51(12):931-43. PubMed ID: 1381457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1992 Apr; 261(1):285-9. PubMed ID: 1313872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIF-1 and Tyr-MIF-1 augment muscimol-stimulated chloride uptake in cerebral cortex.
    Miller LG; Kastin AJ; Roy RB
    Brain Res Bull; 1989 Dec; 23(6):413-5. PubMed ID: 2575438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
    Byrnes JJ; Miller LG; Greenblatt DJ; Shader RI
    Psychopharmacology (Berl); 1993; 111(1):91-5. PubMed ID: 7870939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of benzodiazepines--V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam.
    Lopez F; Miller LG; Greenblatt DJ; Chesley S; Schatzki A; Shader RI
    Neuropharmacology; 1990 Mar; 29(3):237-41. PubMed ID: 1691458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.